The Latest Analyst Ratings for Cabaletta Bio
Portfolio Pulse from Benzinga Insights
In the last quarter, analysts have provided bullish ratings for Cabaletta Bio (NASDAQ:CABA) with 5 bullish and 1 somewhat bullish ratings. Over the past 3 months, 6 analysts have offered 12-month price targets for Cabaletta Bio, with an average price target of $27.17, a high of $39.00 and a low of $17.00. The average price target has increased by 87.38% over the past month.
October 04, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided bullish ratings for Cabaletta Bio, with an average price target of $27.17, indicating a positive outlook for the stock.
The bullish ratings and increased price target suggest that analysts have a positive outlook for Cabaletta Bio. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100